Results 191 to 200 of about 11,242 (227)

A Novel Method for Prognostic Risk Classification After Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Using Data-Mining Methods. [PDF]

open access: yesCancer Sci
Hayashi K   +9 more
europepmc   +1 more source

SUPERCONDUCTING GANTRY FOR CARBON-ION RADIOTHERAPY

open access: yesSUPERCONDUCTING GANTRY FOR CARBON-ION RADIOTHERAPY
openaire  

Clinical Indications for Carbon Ion Radiotherapy

Clinical Oncology, 2018
Compared with photon and proton therapy, carbon ion radiotherapy (CIRT) offers potentially superior dose distributions, which may permit dose escalation with the potential for improved sparing of adjacent normal tissues. CIRT has increased biological effectiveness leading to increased tumour killing compared with other radiation modalities.
Mohamad, O., Yamada, S., Durante, M.
openaire   +3 more sources

Carbon Ion Radiotherapy for Skull Base Chordoma [PDF]

open access: yesSkull Base, 2009
To present the results of the clinical study of carbon ion radiotherapy (CIRT) for skull base and paracervical spine tumors at the National Institute of Radiological Sciences in Chiba, Japan.The study is comprised of three protocols: a pilot study, a phase I/II dose escalation study, and a phase II study.
Hirohiko Tsujii   +2 more
exaly   +3 more sources

Radiotherapy with beams of carbon ions

Reports on Progress in Physics, 2005
In cancer treatment, the introduction of MeV bremsstrahlung photons has been instrumental in delivering higher doses to deep-seated tumours, while reducing the doses absorbed by the surrounding healthy tissues. Beams of protons and carbon ions have a much more favourable dose-depth distribution than photons (called ‘x-rays’ by medical doctors) and are ...
Ugo Amaldi, Gerhard Kraft
openaire   +1 more source

Carbon Ion Radiotherapy for Unresectable Retroperitoneal Sarcomas

International Journal of Radiation Oncology*Biology*Physics, 2009
To evaluate the applicability of carbon ion radiotherapy (CIRT) for unresectable retroperitoneal sarcomas with regard to normal tissue morbidity and local tumor control.From May 1997 to February 2006, 24 patients (17 male and 7 female) with unresectable retroperitoneal sarcoma received CIRT. Age ranged from 16 to 77 years (median, 48.6 years).
Itsuko, Serizawa   +8 more
openaire   +2 more sources

Carbon ion radiotherapy in the treatment of gliomas: a review

Journal of Neuro-Oncology, 2019
Gliomas are among the most common primary brain malignancies, with a poor prognosis for high grade gliomas despite aggressive therapy. Carbon ions, which exhibit favorable biological and physical characteristics, have recently been studied in intracranial malignancies as a way to escalate dose to the tumor while minimizing dose to normal tissue.Pubmed ...
Timothy D. Malouff   +3 more
openaire   +2 more sources

Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer

Pancreas, 2020
Abstract Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness,
Timothy D, Malouff   +7 more
openaire   +2 more sources

Results of carbon ion radiotherapy in 152 patients

International Journal of Radiation Oncology*Biology*Physics, 2004
This study summarizes the experience with raster scanned carbon ion radiation therapy (RT) at the Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany since 1997.Between December 1997 and December 2002, 152 patients were treated at GSI with carbon ion RT.
Daniela, Schulz-Ertner   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy